Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients

Meta-analysis of the efficacy and safety of sevelamer as hyperphosphatemia therapy for hemodialysis patients

This study was designed to examine the relative safety and efficacy of sevelamer in the treatment of chronic kidney disease (CKD) patients in comparison to placebo, calcium carbonate (CC), or lanthanum carbonate (LC). The PubMed, Embase, Cochrane Library, and China National Knowledge Infrastructure...

Full description

Bibliographic Details
Main Authors:	Qian Zeng, Yuanlong Zhong, Xiqiu Yu
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2023-12-01
Series:	Renal Failure
Subjects:	Sevelamer hyperphosphatemia chronic kidney disease meta-analysis
Online Access:	https://www.tandfonline.com/doi/10.1080/0886022X.2023.2210230

Similar Items

Efficacy of Lanthanum Carbonate and Sevelamer Carbonate as Phosphate Binders in Chronic Kidney Disease—A Comparative Clinical Study
by: Parminder Nain, et al.
Published: (2023-02-01)

Correction of hyperphosphatemia in hemodialysis patients: 12-month findings from a randomized study
by: I.O. Dudar, et al.
Published: (2022-08-01)

Effect of sevelamer on serum phosphorus levels in chronic kidney disease and hemodialysis patients; a systematic review and meta-analysis
by: Farshad Gharebakhshi, et al.
Published: (2024-01-01)

Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial
by: Kullaya Takkavatakarn, et al.
Published: (2021-09-01)

Correction of hyperphosphatemia in a patient with end-stage chronic kidney disease and a complex case of anemia. A clinical case
by: Victor V. Fomin
Published: (2024-05-01)

A network meta-analysis of therapies for hyperphosphatemia in CKD based on randomized trials
by: Congyang Zheng, et al.
Published: (2025-01-01)

Phosphate binder in dialysis: a cross-sectional study of patients' adherence and pill burden
by: Brunelle Bruna Scavello Coelho Ferezin, et al.
Published: (2025-01-01)

Ferric citrate for the treatment of hyperphosphatemia and iron deficiency anaemia in patients with NDD-CKD: a systematic review and meta-analysis
by: Xueying Ding, et al.
Published: (2024-03-01)

Research advances on the pathogenesis of vascular calcification caused by hyperphosphatemia associated with chronic kidney disease
by: Wang Yu-han, et al.
Published: (2025-02-01)

Hyperphosphatemia in chronic kidney disease
by: S. A. Martynov, et al.
Published: (2019-10-01)

Efficacy and safety of tenapanor in end-stage renal disease patients with hyperphosphatemia: a systematic review and meta-analysis
by: Shanshen Yu, et al.
Published: (2024-12-01)

Clinical Evaluation of Niacin in Hemodialysis Patients with Hyperphosphatemia as Adjuvant to Calcium Carbonate
by: Rana Bahaa Mohammed, et al.
Published: (2020-09-01)

Clinical Characteristics and Outcomes of Hyperphosphatemia in Patients with Chronic Kidney Disease Stages 1–2
by: Chao Xie, et al.
Published: (2024-07-01)

Case report: Sevelamer-associated colitis—a cause of pseudotumor formation with colon perforation and life-threatening bleeding
by: Margareta Fistrek Prlic, et al.
Published: (2023-04-01)

Understudied Hyperphosphatemia (Chronic Kidney Disease) Treatment Targets and New Biological Approaches
by: Ajeeta Anand, et al.
Published: (2023-05-01)

Repurposing of sevelamer as a novel antidote against aluminum phosphide poisoning: An in vivo evaluation
by: Reza Heidari, et al.
Published: (2023-04-01)

Cardiovascular problems in dialysis patients - focus on correcting hyperphosphatemia
by: A. M. Essaian, et al.
Published: (2020-10-01)

The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and hs-CRP in Patients with Diabetic Nephropathy
by: Sosan Mohammadi Kebar, et al.
Published: (2018-04-01)

Key regulators of vascular calcification in chronic kidney disease: Hyperphosphatemia, BMP2, and RUNX2
by: Xinhua Liang, et al.
Published: (2024-09-01)

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis
by: Yuki Tsuji, et al.
Published: (2020-06-01)

Sevelamer Use in End-Stage Kidney Disease (ESKD) Patients Associates with Poor Vitamin K Status and High Levels of Gut-Derived Uremic Toxins: A Drug–Bug Interaction?
by: Lu Dai, et al.
Published: (2020-05-01)

Is There Any Link between Hyperphosphatemia, Hypoalbuminemia, and Hypocalcemia with Hospital Outcomes in COVID-19 patients?
by: Atefeh Rezaeifar, et al.
Published: (2023-01-01)

Spurious Hyperphosphatemia in a Patient with Multiple Myeloma: A Case Report
by: Thakorn Pruktanakul, et al.
Published: (2021-07-01)

Effect of a transtheoretical model-based intervention and motivational interviewing on hyperphosphatemia management via telehealth (TMT program) among hemodialysis patients during the COVID-19 pandemic
by: Arrom Thongsunti, et al.
Published: (2024-11-01)

Aging‐related hyperphosphatemia impairs myogenic differentiation and enhances fibrosis in skeletal muscle
by: Patricia Sosa, et al.
Published: (2021-10-01)

Severe hyperphosphatemia after oral laxative administration in a 7-year-old patient
by: Çağlar Ödek, et al.
Published: (2016-02-01)

DAXX mediates high phosphate-induced endothelial cell apoptosis in vitro through activating ERK signaling
by: Shu Wang, et al.
Published: (2020-06-01)

Hyperphosphatemia-Induced Oxidant/Antioxidant Imbalance Impairs Vascular Relaxation and Induces Inflammation and Fibrosis in Old Mice
by: Ana Asenjo-Bueno, et al.
Published: (2021-08-01)

Safety and Phosphate‐Binding Capacity of Oxylanthanum Carbonate in Healthy Volunteers
by: Pablo E. Pergola, et al.
Published: (2025-01-01)

Relation of albuminuria to some complications of chronic kidney disease in children: a single-center cross-sectional study
by: Nourhan Essam Aboumosalam, et al.
Published: (2024-11-01)

Family-centered empowerment approach to optimize phosphate management among hemodialysis patients: an experimental study
by: Parvaneh Vasli, et al.
Published: (2023-09-01)

Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: A cross-sectional study
by: Xiaojing Yin, et al.
Published: (2023-04-01)

Prognostic value of serum phosphate levels in sepsis: a systematic review and meta-analysis
by: Shengfeng Wei, et al.
Published: (2023-10-01)

Evaluation of a phosphate kinetics model in hemodialysis therapy—Assessment of the temporal robustness of model predictions
by: Sisse H. Laursen, et al.
Published: (2023-12-01)

Corrigendum: Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: a cross-sectional study
by: Xiaojing Yin, et al.
Published: (2023-06-01)

The Relationship Between Fracture and Mortality in a Chinese Maintenance Hemodialysis Patients Cohort
by: Liu X, et al.
Published: (2024-05-01)

The Efficacy and Safety of Roxadustat for Anemia in Hemodialysis Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials
by: Yunling Geng, et al.
Published: (2024-11-01)

AI-Powered Renal Diet Support: Performance of ChatGPT, Bard AI, and Bing Chat
by: Ahmad Qarajeh, et al.
Published: (2023-09-01)

The value of proteomic studies of the latest markers of kidney damage in the urine to assess the course, progression and complications in patients with CKD
by: L.D. Denova
Published: (2022-06-01)

Genetic Evidence for a Causal Role of Serum Phosphate in Coronary Artery Calcification: The Rotterdam Study
by: Natalia Campos‐Obando, et al.
Published: (2022-08-01)